Topical Management of arterial and venous ulcers - VascularWeb

More documents

Recommendations

Info

Other situations• Eschar• Debriding agents• Negative pressuredevices
Negative pressure compared tomoist wound therapy for DFUs• Blume et al• Daibetes Care2008;31:631-6• R<strong>and</strong>omized 342patients with DFUs toVAC compared tohydrogel or alginate• % closure at 16weeks45403530252015105043%VAC29%MWCP = 0.007
Page 1 and 2: Professor of Surgery Chief, Divisio
Page 3 and 4: DisclosuresScientific Consultant•
Page 6 and 7: Venous/lymphatic ulcer• Common as
Page 8 and 9: • May be inatypicallocations• T
Page 10: Causes of Atypical WoundsInfectious
Page 13 and 14: When to biopsy a• Long durationch
Page 15 and 16: Rx protocol for VLU• Compression
Page 17 and 18: Coexistent arterial insufficiency:H
Page 19 and 20: Topical therapy• Wound debridemen
Page 21 and 22: Special considerations forpatients
Page 23 and 24: How much to debride?
Page 25 and 26: The necrotic toe
Page 27 and 28: Wound bacterial load• Bacterial c
Page 29 and 30: Biofilm/bacterial burden
Page 31 and 32: Wound bacteria data - chronicVLU•
Page 33 and 34: Vulcan trial• Michaels et al Br J
Page 35 and 36: What to put on the wound?• Over 5
Page 37 and 38: Demonstrated effects of chronicwoun
Page 39 and 40: Exudate Management:DressingsNone Lo
Page 41 and 42: Hydrocolloids• Provide barrier if
Page 43: Foams, Specialty absorbents• High

Topical Management of arterial and venous ulcers - VascularWeb

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?